☆
Watchlist
Log in
Sign-up
Fiji Kava Ltd (fij) Logo

Fiji Kava Ltd (FIJ)

___:___ · Consumer Defensive
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

FIJ Chart

Snapshot

FIJ's Principal Activity is the the Group is a medical kava company based in Australia and has established a nucleus farm near Levuka, on the island of Ovalau, Fiji. The Company sells its range of TGA and FDA compliant Fiji Kava products online and in Australia, Fiji, New Zealand, China and the United States. The Company plans to conduct human clinical trials to test the efficacy of Fiji Kavas products and specific kava cultivars, targeting a range of medical conditions.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -63.10%
vs ASX 200 (1yr) -53.65%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,063 of 2,411
Sector Rank 81 of 96

Key Fundamentals

Shares Issued
Sector Consumer Defensive
Similar Companies FFF / WNR / ERG
EPS -$0.031
DPS $0.00
Book Value Per Share $0.02

Broker Consensus

FIJ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

Fiji Kava Ltd (FIJ), an Australian-Fijian medicinal kava health & wellness company, producing natural noble kava products for the natural medicine market. Fiji Kava is focussed on expanding the availability of noble kava products throughout western markets to provide a natural alternative to prescription medicines to promote sleep, soothe and calm the nerves, support muscle relaxation and relax the mind.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office West End QLD 4101
Website www.fijikava.com
Registry Automic Group
Auditor Hall Chadwick QLD
Date Listed 20 Dec 2018

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Prelim)
15/09/2022 Report (Annual)
27/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.
Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Dr Anthony Noble Chief Executive Officer,Managing Director May 2021

Dr Anthony Noble

Chief Executive Officer,Managing Director

No Profile Reported in Annual Report

Mr Jack Theseus Lowenstein Non-Executive Director Aug 2020

Mr Jack Theseus Lowenstein

Non-Executive Director

Mr Lowenstein is an experienced ASX listed company director, who also has corporate history in Fiji, where he was the co-founder of the country's first investment bank, Kontiki Capital Ltd. Mr Lowenstein is a director and shareholder in Kinetic and has invested in Fiji Kava both pre and post IPO. Mr Lowenstein is currently a director of ASX listed Morphic Ethical Equities Fund Ltd, which is managed by Morphic Asset Management, which he co-founded in 2012. Morphic Asset Management was acquired by Ellerston Capital in 2019. Prior to establishing Morphic, Mr Lowenstein spent 14 years with global stock investor Hunter Hall International, where he rose to become deputy chairman of the ASX listed parent company and a director of Hunter Hall Global Value Ltd. His career as a non-executive director began in 1997 when he joined the board of the iconic, but troubled ASX listed window furnishings company Kresta. In 1999, he joined the board of the embattled ASX listed global reinsurance company ReAC.
Mr Nicholas (NicK) Simms Non-Executive Director Sep 2019

Mr Nicholas (NicK) Simms

Non-Executive Director

Mr Simms has decades of experience as an FMCG sector and listed-company CEO roles, including with Bubs Australia, where he oversaw the transition of Bubs from a small private entity to an ASX300 company.
Dr Andrew Kelly Non-Executive Chairman,Non-Executive Director Dec 2018

Dr Andrew Kelly

Non-Executive Chairman,Non-Executive Director

Dr Kelly is Executive Director and Co-Founder of Bio Pacific Partners. He has experience across the Australian biotech scene. His 35-year career spans discovery science to success, focusing in equal measures on research, commercialisation and investment. Dr Kelly is currently Executive Director of Bio Pacific Investments Ltd (NZ) and Bio Pacific Partners Pty Ltd (Australia). He has previously been Director of Focus Genetics Ltd (NZ), Horizon Science Ltd (AU), Bio Pacific Ventures Ltd (NZ), Anzamune Ltd (NZ), CMP Therapeutics Ltd (UK), Wool Equities, Encoate Ltd (NZ), Cleveland Biosensors Ltd (AU), Inner Vision Ltd (NZ), Ultrafine Merino company Ltd (NZ), and Velvet Antler Research New Zealand Ltd (NZ). He is a member of the Due Diligence Committee.
Mr Zane Yoshida Non-Executive Director Dec 2018

Mr Zane Yoshida

Non-Executive Director

Mr Yoshida has experience over many decades in the kava industry. He is a Member of the National Codex Committee, Executive Committee Member of the Australia Fiji Business Council and the Fiji Kava Taskforce Committee, and Chair of the Fiji-based subsidiary of Fiji Kava, South Pacific Elixirs Ltd as well as join the Board of its US subsidiary,Fiji Kava Inc.
Mr Jay Richard Stephenson Company Secretary Feb 2018

Mr Jay Richard Stephenson

Company Secretary

Mr Stephenson has been part of business development for over 30 years, including approximately 26 years as Director, Chief Executive Officer, and Company Secretary of listed and unlisted entities in resources, manufacturing, wine, hotels and property. He has been part of business acquisitions, mergers, initial public offerings, capital raisings, and business restructuring, as well as managing all areas of finance for companies. Mr Stephenson is a Non-Executive Director of and Dragon Mountain Gold Limited since July 2011, Strategic Minerals Corporation NL since 2009, Stonehorse Energy Limited since July 2011, and a former Non-Executive Director of Doray Mining Limited (August 2009 to April 2019), Chairman, Non-Executive Director of Auctus Alternative Investments Limited (February 2011 - March 2019), Drake Resources Limited (2005 to December 2017) and Blina Minerals Limited (October 2016 to April 2019). He is a member of the Due Diligence Committee.
Show All

Director Transactions

FIJ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
11/04/22 Anthony Noble Buy +25,000 $0.069 $1,715 On-market trade
08/04/22 Zane Yoshida Buy +55,000 $0.068 $3,740 On-market trade
04/04/22 Zane Yoshida Buy +25,245 $0.67 $16,914 Participation in share purchase plan
31/03/22 Anthony Noble Buy +100,000 $0.059 $5,900 On-market trade
20/12/21 Andrew Kelly Expiry 750,000 $0.069 $51,750 Options expired
01/12/21 Zane Yoshida Buy +125,000 $0.08 $10,000 Participation in share purchase plan
01/12/21 Jack Lowenstein Buy +500,000 $0.08 $40,000 Participation in share purchase plan
01/12/21 Andrew Kelly Buy +62,500 $0.08 $5,000 Participation in share purchase plan
30/06/21 Zane Yoshida Transfer 1,700,000 $0.10 $170,000 Off-market transfer
23/06/21 Zane Yoshida Sell +50,000 $1.00 ($49,999) On-market trade
29/12/20 Zane Yoshida Buy +750,000 $0.10 $75,000 Off-market trade
22/12/20 Nicholas (NicK) Simms Issued 1,000,000 $0.11 $110,000 Issue of options
22/12/20 Jack Lowenstein Issued 750,000 $0.11 $82,500 Issue of options
05/08/20 Nicholas (NicK) Simms Buy +441,176 $0.057 $25,000 Conversion of convertible notes
05/08/20 Nicholas (NicK) Simms Exercise 1 $25,000.00 $25,000 Conversion of convertible notes
05/08/20 Nicholas (NicK) Simms Issued 1 $0.00 $0 Issue of securities
20/03/20 Andrew Kelly Buy +43,112 $0.035 $1,508 On-market trade
12/03/20 Zane Yoshida Transfer 20,000 $0.06 $1,200 Off-market transfer
12/03/20 Zane Yoshida Transfer 20,000 $0.06 $1,200 Off-market transfer
12/03/20 Zane Yoshida Buy +45,000 $0.066 $2,970 On-market trade
12/03/20 Zane Yoshida Buy +45,000 $0.066 $2,970 On-market trade
12/03/20 Zane Yoshida Transfer 20,000 $0.06 $1,200 Off-market transfer
12/03/20 Zane Yoshida Transfer 20,000 $0.06 $1,200 Off-market transfer
10/03/20 Zane Yoshida Buy +20,000 $0.075 $1,500 On-market trade
10/03/20 Zane Yoshida Buy +20,000 $0.075 $1,500 On-market trade
09/03/20 Andrew Kelly Buy +400,000 $0.076 $30,400 On-market trade
09/03/20 Andrew Kelly Buy +400,000 $0.076 $30,400 On-market trade
27/12/19 Andrew Kelly Buy +244,918 $0.075 $18,369 On-market trade
27/12/19 Zane Yoshida Buy +15,000 $0.089 $1,335 On-market trade
27/12/19 Nicholas Simms Issued 750,000 $0.075 $56,250 Issue of securities
Show All

Director Interests

The current holdings of FIJ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Anthony Noble 11/04/2022 125,000 N/A N/A N/A
Zane Yoshida 08/04/2022 256,959 12,965,314 N/A N/A
Andrew Kelly 20/12/2021 863,776 N/A 0 N/A
Jack Lowenstein 01/12/2021 410,000 3,458,189 1,450,000 N/A
Nicholas (NicK) Simms 22/12/2020 0 441,176 1,750,000 0
Jay Stephenson 11/08/2020 0 N/A N/A N/A
Show All

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 27, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Yoshida Holdings Pte Ltd 12,965,314 8.89%
Project 1 Holdings Pty Ltd (Project 1 A/C) 6,900,000 4.73%
Avanteos Investments Limited (Warczak Super Fund A/C) 5,113,188 3.50%
BNP Paribas Nominees Pty Ltd (Ib Au Noms Retail Client Drp) 5,040,246 3.45%
National Nominees Limited 4,923,462 3.37%
One Managed Investment Funds Ltd(Strategic Global A/C 4,444,769 3.05%
911 Capital Pty Ltd 3,532,500 2.42%
Cs Third Nominees Pty Limited(Bsbs Cust Nom Au Ltd) 2,600,000 1.78%
Kinetic Growth Fund 2,492,048 1.71%
Mr Ian Alastair Leete & Mrs Helen Leetemial Enterprises Pty Ltd (Dashian Family A/C) 2,399,906 1.64%
Ernest W Moody (Revocable A/C) 2,359,010 1.62%
BNP Paribas Nominees Pty Ltd (Drp A/C) 2,257,574 1.55%
Mial Enterprises Pty Ltd(Dashian Family A/C)Great Southern Flour Mills Pty Ltd 1,825,000 1.25%
Mr Matthew Reede 1,811,111 1.24%
Project 1 Superannuation Pty Ltd(Project 1 Super Fund) 1,550,000 1.06%
Mr Matthew Crawford Reede 1,500,000 1.03%
James Stephen Tonkin 1,469,507 1.01%
Citicorp Nominees Pty Limited 1,436,422 0.98%
Tu Investments Pty Ltd (Tu Family Super Fund A/C) 1,416,667 0.97%
Teppwood Investment Pty Ltd (The Copplin Super A/C)Tuinvestments Pty Ltd (Tu Family Super Fund A/C) 1,416,155 0.97%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 28 346 345 552 190 1,461

Substantial Shareholders

No Substantial Shareholders for FIJ in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
30-06-21 Zane Yoshida 1,750,000 11.4 10.01

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.095 30 June
2020 $0.073 30 June
2019 $0.08 28 June
FIJ Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.